Use of the new Da Vinci Xi during robotic rectal resection for cancer: technical considerations and early experience

Int J Colorectal Dis. 2015 Sep;30(9):1281-3. doi: 10.1007/s00384-015-2350-3. Epub 2015 Aug 9.

Authors

Luca Morelli¹, Simone Guadagni, Gregorio Di Franco, Matteo Palmeri, Giovanni Caprili, Cristiano D'Isidoro, Roberta Pisano, Andrea Moglia, Vincenzo Ferrari, Giulio Di Candio, Franco Mosca

Affiliation

¹ General Surgery Unit, Department of Oncology, Transplantation, and New Technologies, University of Pisa, 2 Via Paradisa, Pisa, 56124, Italy.

PMID: 26255257
DOI: 10.1007/s00384-015-2350-3

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Antimetabolites, Antineoplastic / therapeutic use
Blood Loss, Surgical
Capecitabine / therapeutic use
Chemoradiotherapy, Adjuvant
Clinical Competence
Equipment Design
Female
Humans
Learning Curve
Male
Middle Aged
Neoadjuvant Therapy
Operative Time
Patient Positioning
Rectal Neoplasms / surgery*
Rectal Neoplasms / therapy
Robotic Surgical Procedures / instrumentation
Robotic Surgical Procedures / methods*

Substances

Antimetabolites, Antineoplastic
Capecitabine